Austrian authorities have ordered a recall of a cancer medication that was put on the market without proper approval.
Melphalan is a commonly injected in a solution to treat certain bone marrow cancers. But government medical authorities said Wednesday that "Melphalan Koanaa"—which comes from India—was packaged in Austria by a local company and marketed without official approval.
Austria's food and drug agency said Wednesday that initial results from analyzing the medication suggest it is safe. It and the Health Ministry say they have filed a criminal complaint against the Austrian company.
Explore further: Novartis insists its flu vaccines are safe